Dually Labeled Neurotensin NTS


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
11 Sep 2024
Historique:
medline: 12 9 2024
pubmed: 12 9 2024
entrez: 11 9 2024
Statut: aheadofprint

Résumé

The determination of ligand-receptor binding affinities plays a key role in the development process of pharmaceuticals. While the classical radiochemical binding assay uses radioligands, fluorescence-based binding assays require fluorescent probes. Usually, radio- and fluorescence-labeled ligands are dissimilar in terms of structure and bioactivity, and can be used in either radiochemical or fluorescence-based assays. Aiming for a close comparison of both assay types, we synthesized tritiated fluorescent neurotensin receptor ligands ([

Identifiants

pubmed: 39261089
doi: 10.1021/acs.jmedchem.4c01470
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Fabian J Ertl (FJ)

Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraβe 31, D-93053 Regensburg, Germany.

Sergei Kopanchuk (S)

Institute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.

Nicola C Dijon (NC)

School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, U.K.

Santa Veikšina (S)

Institute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.

Maris-Johanna Tahk (MJ)

Institute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.

Tõnis Laasfeld (T)

Institute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.

Franziska Schettler (F)

Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraβe 31, D-93053 Regensburg, Germany.

Albert O Gattor (AO)

Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraβe 31, D-93053 Regensburg, Germany.

Harald Hübner (H)

Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich Alexander University, Nikolaus-Fiebiger-Straβe 10, D-91058 Erlangen, Germany.

Nataliya Archipowa (N)

Institute of Biophysics and Physical Biochemistry, Faculty of Biology and Preclinical Medicine, University of Regensburg, Universitätsstraβe 31, D-93053 Regensburg, Germany.

Johannes Köckenberger (J)

Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich Alexander University, Nikolaus-Fiebiger-Straβe 10, D-91058 Erlangen, Germany.

Markus R Heinrich (MR)

Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich Alexander University, Nikolaus-Fiebiger-Straβe 10, D-91058 Erlangen, Germany.

Peter Gmeiner (P)

Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich Alexander University, Nikolaus-Fiebiger-Straβe 10, D-91058 Erlangen, Germany.

Roger J Kutta (RJ)

Institute of Physical and Theoretical Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraβe 31, D-93053 Regensburg, Germany.

Nicholas D Holliday (ND)

School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, U.K.

Ago Rinken (A)

Institute of Chemistry, University of Tartu, Ravila 14a, 50411 Tartu, Estonia.

Max Keller (M)

Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraβe 31, D-93053 Regensburg, Germany.

Classifications MeSH